Page last updated: 2024-10-27

fluphenazine enanthate and Dyskinesia, Drug-Induced

fluphenazine enanthate has been researched along with Dyskinesia, Drug-Induced in 5 studies

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research Excerpts

ExcerptRelevanceReference
"The fluphenazine treatment produced VCMs in the majority of the treated rats (87% after 24 weeks)."1.34Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats. ( Braga, AL; Calixto, JB; Fachinetto, R; Ferreira, J; Paixão, MW; Pereira, RP; Puntel, RL; Rocha, JB; Villarinho, JG; Wagner, C, 2007)
"Haloperidol was given first in doses of 1."1.27Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review. ( Domino, EF, 1985)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fachinetto, R1
Villarinho, JG1
Wagner, C1
Pereira, RP1
Puntel, RL1
Paixão, MW1
Braga, AL1
Calixto, JB1
Rocha, JB1
Ferreira, J1
Glazer, WM1
Domino, EF3
Kovacic, B2

Reviews

1 review available for fluphenazine enanthate and Dyskinesia, Drug-Induced

ArticleYear
Depot fluphenazine: risk/benefit ratio.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5 Pt 2

    Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe

1984

Trials

1 trial available for fluphenazine enanthate and Dyskinesia, Drug-Induced

ArticleYear
Depot fluphenazine: risk/benefit ratio.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5 Pt 2

    Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe

1984

Other Studies

4 other studies available for fluphenazine enanthate and Dyskinesia, Drug-Induced

ArticleYear
Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.
    Psychopharmacology, 2007, Volume: 194, Issue:3

    Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Benzene Derivatives; Disease Models,

2007
Monkey models of tardive dyskinesia.
    Modern problems of pharmacopsychiatry, 1983, Volume: 21

    Topics: Animals; Benztropine; Biperiden; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fl

1983
A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
    Journal of clinical psychopharmacology, 1982, Volume: 2, Issue:5

    Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Stre

1982
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Psychopharmacology. Supplementum, 1985, Volume: 2

    Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Thera

1985